Inflammatory effects of phthalates in neonatal neutrophils
- PMID: 20453712
- PMCID: PMC2908957
- DOI: 10.1203/PDR.0b013e3181e5c1f7
Inflammatory effects of phthalates in neonatal neutrophils
Abstract
Hospitalized infants are exposed to numerous devices containing the plasticizer di-(2-ethylhexyl) phthalate. Urinary levels of the phthalate metabolite, mono-(2-ethylhexyl) phthalate (MEHP), are markedly elevated in premature infants. Phthalates inactivate peroxisome proliferator-activated receptor-gamma (PPAR-gamma), a nuclear transcription factor that mediates the resolution of inflammation, a process impaired in neonates. We speculate that this increases their susceptibility to MEHP, and this was analyzed. MEHP inhibited neutrophil apoptosis; neonatal cells were more sensitive than adult cells. In neonatal, but not in adult neutrophils, MEHP also inhibited chemotaxis, stimulated oxidative metabolism, and up-regulated expression of NADPH oxidase-1. In both adult and neonatal neutrophils, MEHP stimulated IL-1beta and VEGF production, whereas IL-8 production was stimulated only in adult cells. In contrast, MEHP-inhibited production of MIP-1beta by adult cells, and Regulated on Activation Normal T Cell Expressed and Secreted (RANTES) by neonatal neutrophils. The effects of MEHP on apoptosis and oxidative metabolism in neonatal cells were reversed by the PPAR-gamma agonist, troglitazone. Whereas troglitazone had no effect on MEHP-induced alterations in inflammatory protein or chemokine production, constitutive IL-8 and MIP-1beta production was reduced in adult neutrophils, and RANTES and MIP-1beta in neonatal cells. These findings suggest that neonatal neutrophils are more sensitive to phthalate-mediated inhibition of PPAR-gamma, which may be related to decreased anti-inflammatory signaling.
Figures





Comment in
-
It's the plastic!: commentary on the article by Vetrano et al. on page 134.Pediatr Res. 2010 Aug;68(2):99. doi: 10.1203/PDR.0b013e3181ebe569. Pediatr Res. 2010. PMID: 20631588 No abstract available.
Similar articles
-
Mono(2-ethylhexyl)phthalate and mono-n-butyl phthalate activation of peroxisome proliferator activated-receptors alpha and gamma in breast.Toxicol Lett. 2006 Jun 1;163(3):224-34. doi: 10.1016/j.toxlet.2005.11.001. Epub 2005 Dec 1. Toxicol Lett. 2006. PMID: 16326050
-
Activation of PPARalpha and PPARgamma by environmental phthalate monoesters.Toxicol Sci. 2003 Aug;74(2):297-308. doi: 10.1093/toxsci/kfg145. Epub 2003 Jun 12. Toxicol Sci. 2003. PMID: 12805656
-
Effects of the environmental contaminants DEHP and TCDD on estradiol synthesis and aryl hydrocarbon receptor and peroxisome proliferator-activated receptor signalling in the human granulosa cell line KGN.Mol Hum Reprod. 2014 Sep;20(9):919-28. doi: 10.1093/molehr/gau045. Epub 2014 Jun 20. Mol Hum Reprod. 2014. PMID: 24950685
-
Mechanisms of phthalate ester toxicity in the female reproductive system.Environ Health Perspect. 2003 Feb;111(2):139-45. doi: 10.1289/ehp.5658. Environ Health Perspect. 2003. PMID: 12573895 Free PMC article. Review.
-
Di (2-ethyl hexyl) phthalate and its metabolite-induced metabolic syndrome: a review of molecular mechanisms.Drug Chem Toxicol. 2025 Mar;48(2):325-343. doi: 10.1080/01480545.2024.2405830. Epub 2024 Sep 25. Drug Chem Toxicol. 2025. PMID: 39322993 Review.
Cited by
-
Urinary phthalate metabolites and biomarkers of oxidative stress in pregnant women: a repeated measures analysis.Environ Health Perspect. 2015 Mar;123(3):210-6. doi: 10.1289/ehp.1307996. Epub 2014 Nov 14. Environ Health Perspect. 2015. PMID: 25402001 Free PMC article.
-
Association of Urinary Phthalates with Self-Reported Eye Affliction/Retinopathy in Individuals with Diabetes: National Health and Nutrition Examination Survey, 2001-2010.J Diabetes Res. 2016;2016:7269896. doi: 10.1155/2016/7269896. Epub 2015 Dec 20. J Diabetes Res. 2016. PMID: 26798652 Free PMC article.
-
Sex-specific difference in placental inflammatory transcriptional biomarkers of maternal phthalate exposure: a prospective cohort study.J Expo Sci Environ Epidemiol. 2020 Sep;30(5):835-844. doi: 10.1038/s41370-020-0200-z. Epub 2020 Feb 3. J Expo Sci Environ Epidemiol. 2020. PMID: 32015430
-
Maternal exposure to di-2-ethylhexylphthalate and adverse delivery outcomes: A systematic review.Reprod Toxicol. 2016 Oct;65:76-86. doi: 10.1016/j.reprotox.2016.07.002. Epub 2016 Jul 10. Reprod Toxicol. 2016. PMID: 27412369 Free PMC article.
-
Metabolomic Markers of Phthalate Exposure in Plasma and Urine of Pregnant Women.Front Public Health. 2018 Oct 22;6:298. doi: 10.3389/fpubh.2018.00298. eCollection 2018. Front Public Health. 2018. PMID: 30406068 Free PMC article.
References
-
- Kambia K, Dine T, Gressier B, Bah S, Germe AF, Luyckx M, Brunet C, Michaud L, Gottrand F. Evaluation of childhood exposure to di(2-ethylhexyl) phthalate from perfusion kits during long-term parenteral nutrition. Int J Pharm. 2003;262:83–91. - PubMed
-
- Loff S, Subotic U, Reinicke F, Wischmann H, Brade J. Extraction of di-ethylhexyl-phthalate from perfusion lines of various material, length and brand by lipid emulsions. J Pediatr Gastroenterol Nutr. 2004;39:341–345. - PubMed
-
- Calafat AM, Needham LL, Silva MJ, Lambert G. Exposure to di-(2-ethylhexyl) phthalate among premature neonates in a neonatal intensive care unit. Pediatrics. 2004;113:e429–e434. - PubMed
-
- Stroheker T, Cabaton N, Nourdin G, Regnier JF, Lhuguenot JC, Chagnon MC. Evaluation of anti-androgenic activity of di-(2-ethylhexyl)phthalate. Toxicology. 2005;208:115–121. - PubMed
-
- Kavlock R, Barr D, Boekelheide K, Breslin W, Breysse P, Chapin R, Gaido K, Hodgson E, Marcus M, Shea K, Williams P. NTP-CERHR Expert Panel Update on the Reproductive and Developmental Toxicity of di(2-ethylhexyl) phthalate. Reprod Toxicol. 2006;22:291–399. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 CA132624/CA/NCI NIH HHS/United States
- CA132624/CA/NCI NIH HHS/United States
- AR055073/AR/NIAMS NIH HHS/United States
- HD058019/HD/NICHD NIH HHS/United States
- K08 HD042036/HD/NICHD NIH HHS/United States
- U54 AR055073/AR/NIAMS NIH HHS/United States
- ES005022/ES/NIEHS NIH HHS/United States
- GM034310/GM/NIGMS NIH HHS/United States
- ES004738/ES/NIEHS NIH HHS/United States
- R01 ES004738/ES/NIEHS NIH HHS/United States
- HD042036/HD/NICHD NIH HHS/United States
- P30 ES005022/ES/NIEHS NIH HHS/United States
- R21 HD058019/HD/NICHD NIH HHS/United States
- R01 CA100994/CA/NCI NIH HHS/United States
- R01 GM034310/GM/NIGMS NIH HHS/United States
- CA100994/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources